Finxx final 5-year analysis: results of the randomized, open-label, phase III trial in medium-to-high risk early breast cancer

    Activity: Talk or presentation › Conference presentation

    Description

    Contributors: Joensuu H, Kellokumpu-Lehtinen P, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, Ahlgren J, Auvinen P, Bono P, Lindman H
    Period10 Dec 2010
    Event titleBreast Cancer Symposium at the San Antonio
    Event typeOther
    Degree of RecognitionInternational